Thrombus and Inflammation Study in Sudden Cardiac DEath (TIDE)
Thrombus and Inflammation in Sudden Cardiac DEath
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75014
- Hôpital Cochin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with sudden cardiac death without coronary artery occlusion
- Patients with acute myocardial infarction due to coronary artery occlusion
- Patients with stable angina treated with coronary angioplasty
- Written informed consent
- Social security
Exclusion Criteria:
- Pregnancy
- Small arteries that preclude the use of aspiration devices
- Sudden death without coronary lesions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1
Sudden cardiac death hospitalized
|
Blood sample and thrombus sample
|
|
Experimental: 2
Acute myocardial infarction
|
Blood sample and thrombus sample
|
|
Experimental: 3
Angioplasty procedures programmed
|
Blood sample and thrombus sample
|
|
Experimental: 4
Sudden cardiac death hospitalized without coronary syndrome
|
Blood sample and thrombus sample
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Age of thrombus collected at the site of acute coronary occlusion.
Time Frame: one day
|
one day
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Local and systemic inflammation and endothelial cell apoptosis in patients with sudden death due to acute coronary occlusion, acute myocardial infarction and stable angina treated with coronary angioplasty.
Time Frame: one day
|
one day
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Xavier JOUVEN, MD, Institut National de la Santé Et de la Recherche Médicale, France
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Heart Diseases
- Death
- Myocardial Ischemia
- Heart Arrest
- Pathological Conditions, Signs and Symptoms
- Death, Sudden, Cardiac
- Acute Coronary Syndrome
- Out-of-Hospital Cardiac Arrest
- Death, Sudden
- Investigative Techniques
- Specimen Handling
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Punctures
- Surgical Procedures, Operative
- Blood Specimen Collection
Other Study ID Numbers
Other Study ID Numbers
- P080201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.